Clinical Trials Directory

Trials / Unknown

UnknownNCT01877746

CZECH-ICIT (CZECH Inflammatory Cardiomyopathy Immunosuppression Trial)

RANDOMIZED, MULTICENTRIC STUDY COMPARING THE EFFECT OF TWO REGIMENS OF COMBINED IMMUNOSUPPRESSIVE THERAPY IN THE TREATMENT OF INFLAMMATORY CARDIOMYOPATHY CZECH-ICIT (CZECH INFLAMMATORY CARDIOMYOPATHY IMMUNOSUPPRESSION TRIAL)

Status
Unknown
Phase
Phase 3
Study type
Interventional
Enrollment
234 (estimated)
Sponsor
St. Anne's University Hospital Brno, Czech Republic · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to compare the effect of combined immunosuppressive therapy given on the top standard medical therapy of chronic heart failure according to current guidelines with standard medical therapy of chronic heart failure alone in patients with infammatory cardiomyopathy (ICM). Suitable subjects are characterized by EMB established presence of myocardial inflammation / negative polymerase chain reaction assay (PCR) findings of cardiotropic infectious agents and with varying duration of heart failure symptoms and left ventricular (LV) systolic dysfunction (phase A). Further, to compare the effect of two regimens of combined immunosuppressive therapy in these patients with ICM (phase B).

Conditions

Interventions

TypeNameDescription
DRUGCombination of prednisone and azathioprine* Prednisone for a total of 90 days, with initial dose 1mg/kg/day p.o., given for 12 days and then tapered every 5 days for 5mg/day to the maintenance dose of 0.2mg/kg/day. The daily dose of Prednisone will be rounded to the nearest value divisible by 5. * Azathioprine for 100 days in total, with dose 1 mg/kg/day. The daily dose of Azathioprine will be rounded to the nearest value divisible by 25.
DRUGCombination of prednisone and azathioprine* Prednisone for a total of 6 months, with initial dose 1mg/kg/day p.o. given for 4 weeks with a subsequent maintenance dose of 0,33 mg/kg/den. The daily dose of Prednisone will be rounded to the nearest value divisible by 5. * Azathioprine for 6 months in total, with dose 2mg/kg/day. The daily dose of Azathioprine will be rounded to the nearest value divisible by 25.
OTHERNo interventionNo intervention, only standard medical therapy

Timeline

Start date
2013-01-01
Primary completion
2015-09-01
Completion
2015-09-01
First posted
2013-06-14
Last updated
2013-06-14

Locations

2 sites across 1 country: Czechia

Source: ClinicalTrials.gov record NCT01877746. Inclusion in this directory is not an endorsement.

CZECH-ICIT (CZECH Inflammatory Cardiomyopathy Immunosuppression Trial) (NCT01877746) · Clinical Trials Directory